BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 22, 2007
View Archived Issues
Enzymatic combinatorial approach for synthesizing new anticoagulant heparan sulfate derivatives
Read More
Alte Biosciences secures rights for therapeutics targeting late-onset depression
Read More
Positive phase IIb results for elocalcitol in BPH
Read More
Phase II omiganan study demonstrates positive results
Read More
Allergan acquires Esprit Pharma
Read More
EnVivo reports progress on major drug programs
Read More
Novel contraceptive agents reported in recent Wyeth patent
Read More
Phase I testing commences for SAR-3419 in non-Hodgkin's lymphoma
Read More
Positive interim safety data found for Vical's phase II CMV vaccine trial
Read More
Second OvaRex MAb phase III trial reaches 118th relapse event
Read More
Pharmion initiates pivotal phase III amrubicin study in small cell lung cancer
Read More
Genentech announces third quarter 2007 results
Read More
ConjuChem reports final results of PC-DAC:Exendin-4 phase I/II trial
Read More
Initial results of phase II boceprevir study show high early virologic response
Read More
Affectis initiates phase II trial for cimicoxib in depression
Read More
Galenica acquires Aspreva
Read More
Isis adds new drug, ISIS-388626, to pipeline for the treatment of type 2 diabetes
Read More
Recent Prolysis patent discloses new antiinfective agents
Read More
Novel agents for treating diabetes disclosed in recent patent literature
Read More
Micromet receives regulatory approval to conduct a phase II MT-103 trial
Read More
Analysis of phase III desmoteplase trial justifies continued development
Read More
Abraxis BioScience's Abraxane receives positive opinion in Europe
Read More
Neuroprotection by C2-8, a polyglutamine aggregation inhibitor, in Huntington's disease model
Read More
GlaxoSmithKline's once-daily Avamys receives positive opinion in Europe
Read More
FDA approves sanofi pasteur's meningococcal vaccine for children
Read More
Targin improves opioid-induced bowel dysfunction in patients with chronic pain
Read More
